PHVS: Pharvaris N.V. Stock

by  •  • Comments Off on PHVS: Pharvaris N.V. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 1,109.86
Enterprise Value ($M) n/a
Book Value ($M) 296.79
Book Value / Share 5.50
Price / Book n/a
NCAV ($M) 295.89
NCAV / Share 5.48
Price / NCAV n/a

Profitability (mra)
Return on Invested Capital (ROIC) -0.45
Return on Assets (ROA) -0.78
Return on Equity (ROE) -0.86

Liquidity (mrq)
Quick Ratio 19.08
Current Ratio 19.08

Balance Sheet (mrq) ($M)
Current Assets 312.28
Assets 313.18
Liabilities 16.39
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Venrock Healthcare Capital Partners III, L.P. 6.50 36.72
02-14 13G/A Viking Global Investors Lp 7.00 13.15
02-13 13G/A Foresite Capital Fund IV, L.P. 7.80 23.10
02-13 13G/A General Atlantic Llc 14.10 70.92
02-09 13G/A Fmr Llc 9.99 56.64
02-08 13G/A LSP V Cooperatieve U.A. 6.80 -1.41
01-25 13D/A venBio Global Strategic Fund III, L.P. 8.40 2.76
01-22 13G/A Bain Capital Life Sciences Fund, L.P. 3.80 -31.82

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-15 3,098 27,825 11.13
2024-11-14 2,042 13,099 15.59
2024-11-13 2,017 18,082 11.15
2024-11-12 6,306 31,598 19.96
2024-11-11 2,788 23,818 11.71

(click for more detail)

Similar Companies
PEPG – PepGen Inc. PGEN – Precigen, Inc.
PHAT – Phathom Pharmaceuticals, Inc. PLRX – Pliant Therapeutics, Inc.
PMVP – PMV Pharmaceuticals, Inc.


Financial data and stock pages provided by
Fintel.io